Kurzfassung

A Phase 2, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of topically-applied AG013 for the attenuation of oral mucositis in subjects with cancers of the head and neck receiving concomitatnt chemoradiation therapy.